Microba Life Sciences (ASX:MAP) EBITDA Margin % : -318.91% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Microba Life Sciences's EBITDA for the six months ended in Dec. 2023 was A$-10.44 Mil. Microba Life Sciences's Revenue for the six months ended in Dec. 2023 was A$3.27 Mil. Therefore, Microba Life Sciences's EBITDA margin for the quarter that ended in Dec. 2023 was -318.91%.

Microba Life Sciences EBITDA Margin % Historical Data

The historical data trend for Microba Life Sciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences EBITDA Margin % Chart

Microba Life Sciences Annual Data

Trend

Jun22

Jun23

EBITDA Margin %

-211.35

-203.25

Microba Life Sciences Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	-	-	-227.85	-187.06	-318.91

Competitive Comparison of Microba Life Sciences's EBITDA Margin %

For the Diagnostics & Research subindustry, Microba Life Sciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microba Life Sciences's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's EBITDA Margin % falls into.

Microba Life Sciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Microba Life Sciences's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-11.016	/	5.42
	=	-203.25 %

Microba Life Sciences's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-10.438	/	3.273
	=	-318.91 %

Microba Life Sciences (ASX:MAP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Microba Life Sciences EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000

Website

https://www.microba.com

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines